In vitro study of phenotypical characteristics of BCG granuloma macrophages over the course of granuloma development

Bulletin of Experimental Biology and Medicine

Volumn 155, Issue 5, 2013, Pages 655-658

  Arkhipov, S A ^a,b   Shkurupy, V A ^a,b   Akhramenko, E S ^a   Solomatina, M V ^a   Iljine, D A ^a  

^a Research Institute of Experimental and Clinical Medicine   (Russian Federation)

^b NOVOSIBIRSK STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

BCG granulomas; cytokines; differentiation clusters; macrophage Polarization; macrophages

Indexed keywords

CD16 ANTIGEN; CD32 ANTIGEN; CD36 ANTIGEN; FIBROBLAST GROWTH FACTOR 2; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CONTROLLED STUDY; DISEASE COURSE; EPITHELIOID CELL; GRANULOMA; GRANULOMATOSIS; IMMUNOPHENOTYPING; IN VITRO STUDY; MACROPHAGE; MALE; MOUSE; MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; POLARIZATION;

ANIMALS; ANTIGENS, CD36; CELL DIFFERENTIATION; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; GRANULOMA; IMMUNOPHENOTYPING; INTERFERON-GAMMA; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; MYCOBACTERIUM BOVIS; PHENOTYPE; RECEPTORS, IGG; SPLEEN; TUBERCULOSIS;

EID: 84885232242     PISSN: 00074888     EISSN: 15738221     Source Type: Journal    
DOI: 10.1007/s10517-013-2218-x     Document Type: Article

References (14)

1. S. A. Arkhipov, V. A. Shkurupy, E. S. Akhramenko, et al., Bull. Exp. Biol. Med., 153, No. 3, 343-347 (2012).
2. S. A. Arkhipov, V. A. Shkurupy, M. V. Solomatin, et al., Bull. Exp. Biol. Med., 154, No. 10, 467-470 (2013).
3. V. A. Shkurupy, Tuberculous Granulomatosis. Cytophysiology and Addressed Therapy [in Russian], Moscow (2007).
4. V. A. Shkurupy, L. B. Kim, I. K. Nikonova, et al., Bull. Exp. Biol. Med., 154, No. 3, 299-302 (2013).
5. S. A. Arkhipov, InTech Book: Understanding Tuberculosis - Analyzing the Origin of Mycobacterium Tuberculosis Pathogenicity, Ed. Pere-Joan Cardona, Croatia (2012), P. 179-206.
6. M. Benoit, B. Desnues, and J. Mege, J. Immunol., 181, No. 6, 3733-3739 (2008).
7. D. C. Dale, L. Boxer, and W. C. Liles, Blood, 112, No. 4, 935-945 (2008).
8. F. Geissmann, S. Gordon, D. A. Hume, et al., Nat. Rev. Immunol., 10, No. 6, 453-460 (2010).
9. S. Gordon, Nat. Rev. Immunol., 3, No. 1, 23-35 (2003).
10. A. Mantovani, A. Sica, S. Sozzani, et al., Trends Immunol., 25, No. 12, 677-686 (2004).
11. H. Nakajima, K. Uchida, A. R. Guerrero, et al., J. Neurotrauma, 29, No. 8, 1614-1625 (2012).
12. J. Orme and C. Mohan, Discov. Med., 13, No. 69, 151-158 (2012).
13. E. Song, N. Ouyang, M. Horbelt, et al., Cell. Immunol., 204, No. 1, 19-28 (2000).
14. I. Zanoni and F. Granucci, Curr. Immunol. Rev., 5, No. 4, 311-325 (2009).